Legacy Investments

Our investment portfolio includes these selected examples. Original underwriting dates shown, with dollar amounts rounded to nearest million.

Legacy Investments

Narcan

11.07.16
$17.5 million
Royalty Acquisition

Tissue Regeneration Therapeutics

06.12.13
$3.3 million
Royalty Acquisition

Nautilus

12.05.12
$22.5 million
Structured Credit

InnoPran XL

05.14.13
$13.0 million
Acquisition & Sublicensing

Tribute

08.08.13
$14.0 million
Structured Credit

SynCardia

12.13.13
$10.0 million
Structured Credit & Synthetic Royalty Financing

Parnell #1

01.23.14
$25.0 million
Structured Credit

Response Genetics

07.30.14
$12.0 million
Structured Credit

ABT

10.10.14
$10.0 million
Structured Credit

PDI

10.13.14
$20.0 million
Structured Credit

Galil

12.10.14
$12.5 million
Structured Credit

Hooper Holmes

04.17.15
$5.0 million
Structured Credit

Nanosphere

05.14.15
$30.0 million
Structured Credit

Parnell #2

11.22.16
$20.0 million
Structured Credit

OraMetrix

12.15.16
$8.5 million
Structured Credit

Hooper Holmes / Provant

05.01.17
$8.5 million
Structured Credit

EyePoint Pharmaceuticals

03.28.18
$20.0 million
Structured Credit

Thermedx LLC

05.05.16
$3.5 million
Structured Credit

Solsys (f/k/a Soluble Systems)

10.26.17
$20.0 million
Structured Credit

Cheetah Medical

01.15.19
$20.0 million
Structured Credit

Aimmune Therapeutics

02.12.19
$5.0 million
Structured Credit

Tenex Health

07.01.16
$9.0 million
Structured Credit

Harrow Health

07.19.17
$21.0 million
Structured Credit

Misonix

09.27.19
$30.0 million
Structured Credit

DxTerity

04.06.15
$9.5 million
Structured Credit

CeloNova BioSciences

07.31.17
$25.0 million
Structured Credit

Thermedx

05.05.16
$0.4 million
Note Financing

acerus pharma logo

Acerus Pharmaceuticals

10.11.18
$11.0 million
Structured Credit

acerus pharma logo

B&D Dental

12.10.13
$6.5 million
Structured Credit

keystone dental logo

Keystone Dental

05.23.16
$20.0 million
Structured Credit

Beleodaq

06.06.18
$7.5 million
Royalty Acquisition

Besivance

04.02.13
$16.0 million
Royalty Acquisition

Trio Healthcare

10.22.20
$3.9 million
Royalty Acquisition

zalviso logo

Zalviso

08.31.20
$4.4 million
Royalty Portfolio Acquisition